Emerging Drug Delivery Technologies & Strategies: Players, Pipelines & Partnerships

Date: September 1, 2011
Pages: 188
Price:
US$ 2,265.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E5C2A930F5FEN
Leaflet:

Download PDF Leaflet

Emerging Drug Delivery Technologies & Strategies: Players, Pipelines & Partnerships
  • An examination of trends and advances in the three major drug delivery sectors
  • Unique sales forecasts to 2020 for key products
  • Critical analyses of 58 specialist developers driving the drug delivery market onwards
Increasingly, pharmaceutical companies are turning to drug delivery developers to overcome a range of challenges in getting novel new medicines and formulations effectively and safely delivered. Indeed, it can be argued that identifying an efficient delivery method is as important as the therapy itself. This new report assesses three key emerging sectors in the drug delivery field that will play a crucial role in tackling a range of delivery issues associated with these new classes of drugs in key therapeutic areas such as cancer, CNS, cardiology, respiratory and ophthalmology.

This report provides a detailed insight into the current and future market and...
  • Provides an overview of the marketplace, outlining current thinking on the technologies being researched and employed
  • Identifies key application areas
  • Appraises currently available products which utilise advanced delivery platforms
  • Examines new product developments from major specialist drug delivery companies, critically analysing their prospects
  • Allows ready comparison on different technologies within a company‚Äôs portfolio.
Use this report to:
  • Assess the strengths and weaknesses of competing products/technologies in the context of specific delivery sectors and development companies
  • Identify and review licensing and collaborative partners
  • Understand the merits and applications of the main approaches being researched.
VOLUME 1 - LIPID-BASED DELIVERY TECHNOLOGIES

ABOUT THE AUTHOR

Dr Cheryl L Barton

EXECUTIVE SUMMARY

INTRODUCTION


Types of lipid-based delivery platforms

APPLICATIONS IN DRUG DISCOVERY AND PRODUCT DEVELOPMENT

Oral & buccal
Parenteral
Pulmonary/Intranasal
Transdermal/Topical

DELIVERY PROFILES

Nano-enabled delivery
Controlled delivery
Targeted delivery

APPLICATIONS IN DIFFERENT THERAPEUTIC AREAS

Oncology
Infectious diseases
CNS & Pain
Respiratory
Cardiology
Ocular
Other

TOP 20 COMPANY PROFILES

AlphaRx Corporation
Aphios Corporation
Aradigm Corporation
Axentis Pharma AG
Azaya Therapeutics
Bio-Path Holdings
Camurus AB
Celsion Corporation
Clavis Pharma ASA
Cornerstone Pharmaceuticals
Insys Therapeutics
Latitude Pharmaceuticals
Lipocine
Marina Biotech
Merrimack Pharmaceuticals
NanoBio Corporation
Novagali Pharma SA
Talon Therapeutics
Taiwan Liposome Company
Tekmira Pharmaceuticals Corporation

UP & COMING LIPID-BAS ED DRUG DELIVERY SPECIALISTS

CONCLUSIONS

BIBLIOGRAPHY & ENDNOTES

VOLUME 2 - POLYMER-BASED DELIVERY TECHNOLOGIES

EXECUTIVE SUMMARY

INTRODUCTION

TYPES OF POLYMER-BAS ED DELIVERY PLATFORMS


Applications in drug discovery and product development
Oral & buccal
Parenteral
Transdermal

DELIVERY TRENDS

Nano-enabled delivery
Controlled delivery
Targeted delivery

THERAPEUTIC TRENDS

Oncology
Neurology & Pain
Cardiology
Gastroenterology
Metabolic
Other

TOP 20 COMPANY PROFILES

Access Pharmaceuticals
Alkermes
BioDelivery Sciences International
BTG International
Calando Pharmaceuticals
Debiopharm Group
Durect Corporation
Expression Genetics

ENDO PHARMACEUTICALS

Enzon Pharmaceuticals
Labopharm
Mersana Therapeutics
Mountain View Pharmaceuticals
Nanocarrier
Nektar Therapeutics
OctoPlus N.V
Samyang Pharmaceuticals
Supratek Pharma
SurModics
Teikoku Pharma USA

UP & COMING POLYMER-BAS ED DRUG DELIVERY SPECIALISTS

OUTLOOK

BIBLIOGRAPHY & ENDNOTES

VOLUME 3 - BIOVECTORS: GENE THERAPIES/RNA THERAPEUTICS/VACCINES

EXECUTIVE SUMMARY

INTRODUCTION

TYPES OF BIOVECTORS


Viral vectors
Adeno-associated virus vectors
Adenovirus vectors
Alphavirus vectors
Lentivirus vectors
Poxvirus vectors
Other viral vectors
Non-viral vectors
Bacteria
Yeast
Advanced drug delivery systems
Lipid-based delivery
Polymeric-based delivery
Delivery devices

APPLICATIONS IN THE DEVELOPMENT OF GENE THERAPIES, RN AI THERAPEUTICS AND VACCINES

DELIVERY TRENDS

Gene Therapies
RNA Therapeutics
Vaccines

THERAPEUTIC TRENDS

Gene Therapies
RNA Therapeutics
Vaccines

TOP 20 COMPANY PROFILES

Gene Therapies
RNA Therapeutics
Vaccines

GENE THERAPY DELIVERY

Ark Therapeutics
Ceregene
Expression Genetics
Neurologix
Oxford BioMedica

RNA THERAPEUTIC DELIVERY SPECIALISTS

Alnylam Pharmaceuticals
Calando Pharmaceuticals
CureVac GmbH
Marina Biotech
Santaris Pharma A/S
Silence Therapeutics
Tekmira Pharmaceutical Corporation

VACCINE DELIVERY SPECIALISTS

Crucell N.V
GlobeImmune
Inovio Pharmaceuticals
Ichor Medical Systems
Juvaris BioTherapeutics
Lipotek Pty
Vical
VIRxSys

UP & COMING GENE THERAPY, RN AI THERAPEUTICS AND VA CCINE DELIVERY SPECIALISTS ?

OUTLOOK

BIBLIOGRAPHY & ENDNOTES

Ask Your Question

Emerging Drug Delivery Technologies & Strategies: Players, Pipelines & Partnerships
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: